Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZZ) Change in Accured Expenses (2021 - 2025)

Historic Change in Accured Expenses for Core Scientific (CORZZ) over the last 5 years, with Q3 2025 value amounting to $34.7 million.

  • Core Scientific's Change in Accured Expenses rose 240946.53% to $34.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.7 million, marking a year-over-year decrease of 112.54%. This contributed to the annual value of $1.9 million for FY2024, which is 9855.81% down from last year.
  • Latest data reveals that Core Scientific reported Change in Accured Expenses of $34.7 million as of Q3 2025, which was up 240946.53% from -$12.5 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Change in Accured Expenses registered a high of $117.4 million during Q4 2023, and its lowest value of -$35.9 million during Q2 2024.
  • Over the past 5 years, Core Scientific's median Change in Accured Expenses value was $4.0 million (recorded in 2021), while the average stood at $12.1 million.
  • As far as peak fluctuations go, Core Scientific's Change in Accured Expenses tumbled by 104249.45% in 2024, and later surged by 240946.53% in 2025.
  • Core Scientific's Change in Accured Expenses (Quarter) stood at $38.3 million in 2021, then plummeted by 54.33% to $17.5 million in 2022, then soared by 571.9% to $117.4 million in 2023, then crashed by 60.17% to $46.8 million in 2024, then decreased by 25.71% to $34.7 million in 2025.
  • Its Change in Accured Expenses was $34.7 million in Q3 2025, compared to -$12.5 million in Q2 2025 and $2.7 million in Q1 2025.